MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 27, 2009; DOI: 10.1124/mol.109.054544


0026-895X/09/7505-1160-1170$20.00
Mol Pharmacol 75:1160-1170, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.109.054544v1
75/5/1160    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilsbach, R.
Right arrow Articles by Hein, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilsbach, R.
Right arrow Articles by Hein, L.

Genetic Dissection of {alpha}2-Adrenoceptor Functions in Adrenergic versus Nonadrenergic Cells

Ralf Gilsbach, Christoph Röser, Nadine Beetz, Marc Brede, Kerstin Hadamek, Miriam Haubold, Jost Leemhuis, Melanie Philipp, Johanna Schneider, Michal Urbanski, Bela Szabo, David Weinshenker, and Lutz Hein

Institute of Experimental and Clinical Pharmacology and Toxicology (R.G., N.B., M.H., J.L., J.S., M.U., B.S., L.H.) and Centre for Biological Signaling Studies (N.B., L.H.), University of Freiburg, Freiburg, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (C.R., M.B., K.H.); Institute of Cell Biology, Duke University, Durham, North Carolina (M.P.); and Department of Human Genetics, Emory University, Atlanta, Georgia (D.W.)

{alpha}2-Adrenoceptors mediate diverse functions of the sympathetic system and are targets for the treatment of cardiovascular disease, depression, pain, glaucoma, and sympathetic activation during opioid withdrawal. To determine whether {alpha}2-adrenoceptors on adrenergic neurons or {alpha}2-adrenoceptors on nonadrenergic neurons mediate the physiological and pharmacological responses of {alpha}2-agonists, we used the dopamine β-hydroxylase (Dbh) promoter to drive expression of {alpha}2A-adrenoceptors exclusively in noradrenergic and adrenergic cells of transgenic mice. Dbh-{alpha}2A transgenic mice were crossed with double knockout mice lacking both {alpha}2A- and {alpha}2C-receptors to generate lines with selective expression of {alpha}2A-autoreceptors in adrenergic cells. These mice were subjected to a comprehensive phenotype analysis and compared with wild-type mice, which express {alpha}2A- and {alpha}2C-receptors in both adrenergic and nonadrenergic cells, and {alpha}2A/{alpha}2C double-knockout mice, which do not express these receptors in any cell type. We were surprised to find that only a few functions previously ascribed to {alpha}2-adrenoceptors were mediated by receptors on adrenergic neurons, including feedback inhibition of norepinephrine release from sympathetic nerves and spontaneous locomotor activity. Other agonist effects, including analgesia, hypothermia, sedation, and anesthetic-sparing, were mediated by {alpha}2-receptors in nonadrenergic cells. In dopamine β-hydroxylase knockout mice lacking norepinephrine, the {alpha}2-agonist medetomidine still induced a loss of the righting reflex, confirming that the sedative effect of {alpha}2-adrenoceptor stimulation is not mediated via autoreceptor-mediated inhibition of norepinephrine release. The present study paves the way for a revision of the current view of the {alpha}2-adrenergic receptors, and it provides important new considerations for future drug development.


Received for publication January 3, 2009.

Accepted for publication February 27, 2009.

Address correspondence to: Dr. Lutz Hein, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Albertstrasse 25, 79104 Freiburg, Germany. E-mail: lutz.hein{at}pharmakol.uni-freiburg.de




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Albarran-Juarez, R. Gilsbach, R. P. Piekorz, K. Pexa, N. Beetz, J. Schneider, B. Nurnberg, and L. Hein
Modulation of {alpha}2-Adrenoceptor Functions by Heterotrimeric G{alpha}i Protein Isoforms
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 35 - 44.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics